Literature DB >> 7752279

Epidemiology of symptomatic mitral valve prolapse in black patients.

M S Zua1, S F Dziegielewski.   

Abstract

This study analyzed the charts of 743 black patients who visited the emergency rom of a Nashville Hospital with symptoms of chest pain, palpitation, or fatigue. One hundred sixty-five met the criteria for the diagnosis of mitral valve prolapse (MVP). Epidemiologic factors of symptomatic MVP in blacks (ie, symptoms reported based on age and sex) were examined to determine whether there are significant differences in the prevalence of symptomatic MVP with relation to black males and females. Similarities were found in the patterns of the ages of both males and females and the symptoms that were reported. No significant differences were found between black males and females, which does not support previous findings.

Entities:  

Mesh:

Year:  1995        PMID: 7752279      PMCID: PMC2607808     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  7 in total

1.  Esophageal dysfunction and chest pain in patients with mitral valve prolapse: a prospective study utilizing provocative testing during esophageal manometry.

Authors:  K L Koch; W R Davidson; F P Day; P F Spears; S R Voss
Journal:  Am J Med       Date:  1989-01       Impact factor: 4.965

Review 2.  Mitral valve prolapse. Evolution and refinement of diagnostic techniques.

Authors:  J K Perloff; J S Child
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

3.  Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study.

Authors:  D D Savage; R J Garrison; R B Devereux; W P Castelli; S J Anderson; D Levy; P M McNamara; J Stokes; W B Kannel; M Feinleib
Journal:  Am Heart J       Date:  1983-09       Impact factor: 4.749

Review 4.  Mitral valve prolapse.

Authors:  R B Devereux; J K Perloff; N Reichek; M E Josephson
Journal:  Circulation       Date:  1976-07       Impact factor: 29.690

5.  Metabolic studies in mitral valve prolapse syndrome. A neuroendocrine--cardiovascular process.

Authors:  H Boudoulas; J C Reynolds; E Mazzaferri; C F Wooley
Journal:  Circulation       Date:  1980-06       Impact factor: 29.690

Review 6.  Two dimensional echocardiography in mitral, aortic and tricuspid valve prolapse. The clinical problem, cardiac nuclear imaging considerations and a proposed standard for diagnosis.

Authors:  J Morganroth; R H Jones; C C Chen; M Naito
Journal:  Am J Cardiol       Date:  1980-12-18       Impact factor: 2.778

Review 7.  Mitral valve prolapse, panic disorder, and chest pain.

Authors:  M A Alpert; V Mukerji; M Sabeti; J L Russell; B D Beitman
Journal:  Med Clin North Am       Date:  1991-09       Impact factor: 5.456

  7 in total
  3 in total

1.  Mitral valve prolapse.

Authors:  T O Cheng
Journal:  J Natl Med Assoc       Date:  1995-11       Impact factor: 1.798

Review 2.  Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis.

Authors:  Francesca N Delling; Ramachandran S Vasan
Journal:  Circulation       Date:  2014-05-27       Impact factor: 29.690

3.  Mitral Valve Prolapse and Its Motley Crew-Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition.

Authors:  Jordan E Morningstar; Annah Nieman; Christina Wang; Tyler Beck; Andrew Harvey; Russell A Norris
Journal:  J Am Heart Assoc       Date:  2021-06-22       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.